SGMO Financials
Sangamo Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.07
Market Cap
$74.57M
P/E Ratio
-0.2
EPS
$-0.49
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$57.80M
Gross Profit
-
Operating Income
-
Net Income
$-97.94M
EPS (Diluted)
$-0.49
Balance Sheet Highlights
Total Assets
$101.64M
Total Liabilities
$78.86M
Shareholders Equity
-
Cash & Equivalents
$41.92M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-67.14M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-169.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SGMO revenue?
SGMO's most recent quarterly revenue was $57.80M. Annual revenue can be calculated by summing the four most recent quarters.
Is SGMO profitable?
SGMO reported a loss of $97.94M in the most recent quarter. The net profit margin is -169.4%.
What is SGMO market cap?
SGMO has a market capitalization of $74.57M, making it a small-cap stock.
Does SGMO have debt?
View SGMO's balance sheet for debt information.
What is SGMO cash flow?
Cash flow data is available in the full financial statements.